Add to my selection

SIRTURO

Medicine - Posted on Oct 02 2025

Active substance (DCI)

bedaquiline

history (3)

9/10/25

SIRTURO (bedaquiline) - Adult and paediatric patients (5 years to less than 18 years of age) with pulmonary tuberculosis (TB)

Summary of opinion Favourable opinion for reimbursement as part of an appropriate combination regimen in adult and paediatri...

CAV :
54321

icône flèche
9/9/20

SIRTURO

Key points Favourable opinion for reimbursement in the indication extension “treatment of pulmonary multidrug-resistant tube...

CAV :
54321

icône flèche
7/22/15

SIRTURO (bedaquiline), antituberculosis agent

Moderate improvement in combination with other antituberculosis agents in the treatment of multidrug resistant pulmonary tub...

CAV :
54321

icône flèche

Technical information

ATC code

J04AK05

Manufacturer

JANSSEN-CILAG

Presentation

SIRTURO 100 mg comprimé
4 plaquette(s) thermoformée(s) aluminium de 6 comprimé(s) (CIP : 34009 300 158 1 0)

All our publications

Pulmonary and pleural diseases